Creo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Creo Medical develops minimally invasive electrosurgical devices designed to improve patient outcomes. With its innovative CROMA and Kamaptive technologies, Creo Medical is setting new standards in precision and flexibility for clinicians across a range of surgical procedures. This funding has been sought to mitigate the completion risk of its recently announced sale of a 51% controlling interest in the group’s European subsidiary, Creo Medical Europe. It also aims to provide balance sheet strength for future growth, as Creo Medical continues to roll out its defined medtech strategy.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, served as advisor to Creo Medical on the transaction.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Banco BPM Vita S.p.A. has launched a voluntary public tender offer for Anima Holding S.p.A.
Banco BPM Vita S.p.A. has initiated a voluntary public tender offer for the shares of Anima Holding S.p.A.
Aprenda másTerra Holding S.r.l. has launched a voluntary public tender offer for Gibus S.p.A.
Terra Holding S.r.l. has initiated a voluntary public tender offer for the shares of Gibus S.p.A.
Aprenda másPharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Aprenda más